Craig F. Arcella is Co‑Head of the Finance Practice. Mr. Arcella represents financial institutions and corporate clients in a wide variety of matters, including investment grade, high‑yield and convertible bond offerings; liability management transactions; initial public offerings and other equity financings; syndicated loan, direct lending and other leveraged finance transactions; and mergers and acquisitions. He also regularly advises companies with respect to governance, public disclosure and other corporate matters.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
International Bar Association
Best Lawyers in America
Chambers Global
Chambers USA
IFLR1000
Latin Lawyer 250: Latin America’s Leading Business Law Firms
Lawdragon
The Legal 500 Hall of Fame
The Legal 500 Latin America
The Legal 500 US
Deals & Cases
January 29, 2026
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with their $1.75 billion registered senior notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes were listed on the Irish Stock Exchange. The transaction closed on January 15, 2026.
Deals & Cases
January 28, 2026
Cravath represented the initial purchasers in connection with the $1 billion 144A/Reg. S high‑yield senior notes offering of Six Flags Entertainment Corporation, Canada's Wonderland Company and Millennium Operations LLC. Six Flags is North America’s largest regional amusement‑resort operator with 26 amusement parks, 15 water parks and nine resort properties across 16 states in the U.S., Canada and Mexico. The transaction closed on January 14, 2026.
Deals & Cases
January 27, 2026
Cravath represented the underwriters in connection with the $6 billion registered notes offering of the State of Israel. The notes will be listed on the London Stock Exchange. The transaction closed on January 13, 2026.
Deals & Cases
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 29, 2025
Cravath represented the underwriters in connection with the $148 million primary common stock offering of Stewart Information Services Corporation. Through its subsidiaries, Stewart Information Services Corporation provides title insurance and real estate transaction services. The transaction closed on December 12, 2025.
Publications
December 29, 2025
On December 23, 2025, Cravath prepared a memo for its clients entitled “Section 16(a) Share Ownership and Transaction Reporting Obligations to Apply to Directors and Officers of Foreign Private Issuers from March 18, 2026.” The memo examines the Holding Foreign Insiders Accountable Act and how directors and officers of foreign private issuers will be required to comply with the share ownership and transaction reporting obligations of paragraph (a) of Section 16 of the Securities Exchange Act of 1934 within 90 days of the enactment of the 2026 U.S. National Defense Authorization Act.
Publications
June 12, 2025
On June 11, 2025, Cravath prepared a memo for its clients entitled “SEC Solicits Public Comment on the Eligibility Criteria for Foreign Private Issuer Status.” The memo examines a concept release recently published by the U.S. Securities and Exchange Commission to seek public comment on whether to revise the “foreign private issuer” definition in light of shifting trends in the characteristics of the FPI population.
Craig F. Arcella is Co‑Head of the Finance Practice. Mr. Arcella represents financial institutions and corporate clients in a wide variety of matters, including investment grade, high‑yield and convertible bond offerings; liability management transactions; initial public offerings and other equity financings; syndicated loan, direct lending and other leveraged finance transactions; and mergers and acquisitions. He also regularly advises companies with respect to governance, public disclosure and other corporate matters.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
Mr. Arcella has been cited as a leading practitioner in securities and corporate law by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000, Lawdragon, The Best Lawyers in America, The Legal 500 Latin America and Latin Lawyer 250. He is “undoubtedly a market leader,” demonstrating “a unique balance of sophistication and creativity” (The Legal 500 US). Mr. Arcella is also cited in Best Lawyers “Best Law Firms” as “best‑in‑class” in devising “innovative solutions to difficult problems.”
Mr. Arcella received a B.A. from Duke University in 1995 and a J.D. from Columbia Law School in 1998, where he was a Harlan Fiske Stone Scholar and a member of the Law Review.
Mr. Arcella joined Cravath in 1998 and was elected a partner in 2006. He worked in Cravath’s Hong Kong office in 1999, in the Firm’s London office from 2001 to 2003, and is currently based in the Firm’s New York office.
International Bar Association
Best Lawyers in America
Chambers Global
Chambers USA
IFLR1000
Latin Lawyer 250: Latin America’s Leading Business Law Firms
Lawdragon
The Legal 500 Hall of Fame
The Legal 500 Latin America
The Legal 500 US
Deals & Cases
January 29, 2026
Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with their $1.75 billion registered senior notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes were listed on the Irish Stock Exchange. The transaction closed on January 15, 2026.
Deals & Cases
January 28, 2026
Cravath represented the initial purchasers in connection with the $1 billion 144A/Reg. S high‑yield senior notes offering of Six Flags Entertainment Corporation, Canada's Wonderland Company and Millennium Operations LLC. Six Flags is North America’s largest regional amusement‑resort operator with 26 amusement parks, 15 water parks and nine resort properties across 16 states in the U.S., Canada and Mexico. The transaction closed on January 14, 2026.
Deals & Cases
January 27, 2026
Cravath represented the underwriters in connection with the $6 billion registered notes offering of the State of Israel. The notes will be listed on the London Stock Exchange. The transaction closed on January 13, 2026.
Deals & Cases
January 08, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 29, 2025
Cravath represented the underwriters in connection with the $148 million primary common stock offering of Stewart Information Services Corporation. Through its subsidiaries, Stewart Information Services Corporation provides title insurance and real estate transaction services. The transaction closed on December 12, 2025.
Publications
December 29, 2025
On December 23, 2025, Cravath prepared a memo for its clients entitled “Section 16(a) Share Ownership and Transaction Reporting Obligations to Apply to Directors and Officers of Foreign Private Issuers from March 18, 2026.” The memo examines the Holding Foreign Insiders Accountable Act and how directors and officers of foreign private issuers will be required to comply with the share ownership and transaction reporting obligations of paragraph (a) of Section 16 of the Securities Exchange Act of 1934 within 90 days of the enactment of the 2026 U.S. National Defense Authorization Act.
Publications
June 12, 2025
On June 11, 2025, Cravath prepared a memo for its clients entitled “SEC Solicits Public Comment on the Eligibility Criteria for Foreign Private Issuer Status.” The memo examines a concept release recently published by the U.S. Securities and Exchange Commission to seek public comment on whether to revise the “foreign private issuer” definition in light of shifting trends in the characteristics of the FPI population.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.